← Browse by Condition
Medical Condition

end stage renal disease esrd

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for end stage renal disease esrd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — end stage renal disease esrd Clinical Trials

How many clinical trials are currently recruiting for end stage renal disease esrd?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for end stage renal disease esrd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for end stage renal disease esrd?
end stage renal disease esrd research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a end stage renal disease esrd clinical trial?
Eligibility criteria for end stage renal disease esrd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Phase 4
1
Top Sponsors
Chengdu Qingshan Likang Pharmaceutical Co., Ltd 1 trial
Mohammad Arian 1 trial
Abu Dhabi Health Services Company 1 trial
Indiana University 1 trial

Recruiting Clinical Trials

NCT06597201 Phase 4
Recruiting
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Enrollment
400 pts
Location
China
Sponsor
Chengdu Qingshan Likang Pharma...
View Trial →
NCT07361146
Recruiting
A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial
Enrollment
72 pts
Location
Kuwait
Sponsor
Mohammad Arian
View Trial →
NCT06836206 Phase 1, Phase 2
Recruiting
The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi
Enrollment
40 pts
Location
United Arab Emirates
Sponsor
Abu Dhabi Health Services Comp...
View Trial →
NCT07033117
Recruiting
RaDIANT Health Systems Intervention
Enrollment
14,000 pts
Location
United States
Sponsor
Indiana University
View Trial →

Related Conditions

chronic kidney disease (1) hemodialysis patients (1) physical rehabilitation during dialysis (1) kidney disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology